Cyclin B-dependent kinase and caspase-1 activation precedes mitochondrial dysfunction in fumarylacetoacetate-induced apoptosis

FASEB Journal

Volumn 13, Issue 15, 1999, Pages 2284-2298

  Jorquera, Rossana ^a   Tanguay, Robert M ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Caspase; Cell cycle; Cell death; Cytochrome c; Glutathione

Indexed keywords

ACETOACETIC ACID DERIVATIVE; ACETYLCYSTEINE; BUTHIONINE SULFOXIMINE; CASPASE 3; CASPASE INHIBITOR; CYCLIN B; CYCLIN DEPENDENT KINASE; CYTOCHROME C; DNA; GLUTATHIONE; INTERLEUKIN 1BETA CONVERTING ENZYME; SUCCINYLACETONE; TYROSINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL SYNCHRONIZATION; CONTROLLED STUDY; DNA STRAND BREAKAGE; ENZYME ACTIVATION; ENZYME DEFICIENCY; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; TYROSINEMIA;

EID: 0032797275     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.15.2284     Document Type: Article

References (49)

1. Lindblad, B., Lindstedt, S., and Steen, G. (1977) On the enzymic defects in hereditary tyrosinemia. Proc. Natl Acad. Sci. USA 74, 4641-4645
2. Tanguay, R. M., Valet, J. P., Lescault, A., Duband, J. L., Laberge, C., Lettre, F., and Plante, M. (1990) Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type 1). Am. J. Hum. Genet. 47, 308-316
3. Phaneuf, D., Lambert, M., Laframboise, R., Mitchell, G., Lettre, F., and Tanguay, R. M. (1992) Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient. J. Clin. Invest. 90, 1185-1192
4. St-Louis, M., and Tanguay, R. M. (1997) Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview. Hum. Mutat. 9, 291-299
5. Mitchell, G. A., Lambert, M., and Tanguay, R. M. (1995) Hypertyrosinemia. In The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds) pp. 1077-1106, McGraw-Hill, New York
6. Weinberg, A., Mize, C., and Worthen, H. (1976) The occurrence of hepatoma in the chronic form of hereditary tyrosinemia J. Pediatr. 88, 434-438
7. Stoner, E., Starkman, H., Wellner, D., Wellner, V. P., Sassa, S., Rifkind, A. B., Grenier, A., Steinberg, P. G., Meister, A., New, M. I., and Levine, L. S. (1985) Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency. Pediatr. Res. 18, 1332-1336
8. Laberge, C., Lescault, A., and Tanguay, R. M. (1986) Hereditary tyrosinemias (type 1): a new vista on tyrosine toxicity and cancer. In Essential Nutrients in Carcinogennis (Poirier, L. A., Newberne, P. M., and Pariza, M. W., eds) pp. 209-221, Plenum Press, New York
9. Tanguay, R. M., Jorquera, R., Poudrier, J., and St-Louis, M. (1996) Tyrosine and its catabolites: from disease to cancer. Acta Biochim. Pol. 43, 209-216
10. Jorquera, R., and Tanguay, R. M. (1997) The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion. Biochem, Biophys. Res. Commun. 232, 42-48
11. Endo, F., Kubo, S., Awata, H., Kiwaki, K., Katoh, H., Kanegae, Y., Saito, I., Miyazaki, J., Yamamoto, T., Jakobs, C., Hattori, S., and Matsuda, I. (1997) Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway. J. Biol. Chem. 272, 24426-24432
12. Kubo, S., Sun, M., Miyahara, M., Umeyama, K., Urakami, K., Yamamoto, T., Jakobs, C., Matsuda, I., and Endo, F. (1998) Hepatocyte injury in tyrosinemia type 1 is induced by fumarylacetoacetate and is inhibited by caspase inhibitors. Proc. Natl. Acad. Sci. USA 95, 9552-9557
13. Ruppert, S., Kelsey, G., Schedl, A., Schmid, E., Thies, E., and Schutz, G. (1992) Deficiency of an enzyme of tyrosine metabolism underlies altered gene expression in newborn liver of lethal albino mice, Genes Dev. 6, 1430-1443
14. Edwards, S. W., and Knox, W. E. (1955) Enzymes involved in conversion of tyrosine to acetoacetate. Methods Enzymol. 2, 292-300
15. Lalande, M. (1990) A reversible arrest point in the late G1 phase of the mammalian cell cycle. Exp. Cell Res. 186, 332-339
16. Gorczyca, W., Gong, J., Ardelt, B., Traganos, F., and Darzynkiewicz., Z. (1993) The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res. 53, 3186-3192
17. Duke, R. C., and Cohen, J. J. (1992) Morphological and biochemical assays of apoptosis. Curr. Prot. Immunol. 1, 3.17.1-3.17.16
18. Gong, J., Traganos, F., and Darzynkiewicz, Z. (1994) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biorhem. 218, 314-319
19. Faure, R., Vincent, M., Dufour, M., Shaver, A., and Posner, B. (1995) Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: studies on a neuronal and a glial cell line. J. Cell. Biochem. 59, 389-401
20. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. (1997) The release of cytochromer from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136
21. Petit, P. X., O'Connor, J. E., Grunwald, D., and Brown, S. C. (1990) Analysis of the membrane potential of rat-and mouseliver mitochondria by flow cytometry and possible applications. Eur. J. Biochem. 194, 389-397
22. Darzynkiewicz., Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M., Lassota, P., and Traganos, F. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795-808
23. Whitacre, C., Hashimoto, H., Tsai, M., Chatterjec, S., Berger, S., and Berger, N. (1995) Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res. 55, 3697-3701
24. Nurse, P. (1990) Universal control mechanism regulating onset of M-phase. Nature (London) 344, 503-508
25. Borgne, A., and Meijer, L. (1996) Sequential dephosphorylation of p34(cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transition. J. Biol. Chem. 271, 27847-27854
26. Davis, F., Tsao, T., Fowler, S., and Rao, P. (1983) Monoclonal antibodies to mitolic cells. Proc. Natl. Acad. Sci. USA 80, 2926-2930
27. Lazebnik, V. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (London) 371, 346-347
28. Margolin, N., Raybuck, S. A., Wilson, K. P., Chen, W., Fox, T., Gu, Y., and Livingston, D. J. (1997) Substrate and inhibitor specificity of interleukin-1β-converting enzyme and related caspases. J. Biol. Chem. 272, 7223-7228
29. Slee, E. A., Zhu, H., Chow, S. C., MacFarlane, M., Nicholson, D. W., and Cohen, G. M. (1996) Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315, 21-24
30. Harvey, K. J., Blomquist, J. F., and Ucker, D. S. (1998) Commitment and effector phases of the physiological cell death pathway elucidated with respect to Bcl-2 caspase, and cyclin-dependent kinase activities. Mol. Cell. Biol. 18, 2912-2922
31. Slee, E., Harte, M., Kluck, R., Wolf, B., Casiano, C., Newmeyer, D., Wang, H., Reed, J., Nicholson, D., Alnemri, E., Green, D., and Martin, S. (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144, 281-292
32. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATH and cytochrome c. Cell 86, 147-157
33. Kluck, R. M., Martin, S. J., Hoffman, B. M., Zhou, J. S., Green, D. R., and Newmeyer, D. D. (1997) Cytochromec activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J. 16, 4639-4649
34. Deckwerth, T. L., and Johnson, E. M. (1993) Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123, 1207-1222
35. Bossy-Wetzel, E., Newmeyer, D. D., and Green, D. R. (1998) Mitochondrial cytochromec release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMKO J. 17, 37-49
36. Medema, J. P., Scaffidi, C., Kischkel, F. C., Shevchenko, A., Mann, M., Krammer, P. H., and Peter, M. E. (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16, 2794-2804
37. Shi, L., Nishioka, W., Th'ng, J., Bradbury, E., Litchfield, D., and Greenberg, A. (1994) Premature p34cdc2 activation required for apoptosis. Science 263, 1143-1145
38. Yao, S.-L., McKenna, K. A., Sharkis, S. J., and Bedi, A. (1996) Requirement of p34cdc2 kinase for apoptosis mediated by the Fas/APO-1 receptor and interleukiu 1β-converting enzymerelated proteases. Cancer Res. 56, 4551-4555
39. Demarcq, C., Bunch, R., Creswell, D., and Eastman, A. (1994) The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells. Cell Growth Differ. 5, 983-993
40. Shimizu, T., O'Connor, P., Kohn, K., and Pommier, Y. (1995) Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res. 55, 228-231
41. O'Connor, P., Ferris, D., White, G., Pines, J., Hunter, T., Longo, D., and Kohn, K. (1992) Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth Differ. 3, 43-52
42. Kohn, K., Jackman, J., and O'Connor, P. (1994) Cell cycle control and cancer chemotherapy. J. Cell. Biochem. 54, 440-452
43. Furnari, B., Rhind, N., and Russell, P. (1997) Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 277, 1495-1497
44. Poon, R. Y. C., Chau, M. S., Yamashita, K., and Hunter, T. (1997) The role of cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 57, 5168-5178
45. Wang, X. W., Zhan, Q., Coursen, J. D., Khan, M. A., Kontny, H. U., Yu, L., Hollander, M. C., O'Connor, P. M., Fornace, A. J., and Harris, C. C. (1999) GADD45 induction of a G2/M cell cycle checkpoint. Proc. Natl. Acad. Sci. USA 96, 3706-3711
46. Ueda, S., Nakamura, H., Masutani, H., Sasada, T., Yonehara, S., Takabayashi, A., Yamaoka, Y., and Yodoi, J. (1998) Redox regulation of caspase-3(-like) protease activity: regulatory roles of thioredoxin and cytochromec. J. Immunol. 161, 6689-6695
47. Voehringer, D. W., McConkey, D. J., McDonnell, T. J., Brisbay, S., and Meyn, R. E. (1998) Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc. Natl, Arad. Ssi. USA 95, 2956-2960
48. Prieto-Alamo, M. J., and Laval, F. (1998) Deficient DNA-ligase activity in the metabolic disease tyrosinemia type 1. Proc. Natl Acad. Sci. USA 95, 12614-12618
49. Edgren, M., Revesz, L., and Larsson, A. (1981) Induction and repair of single-strand DNA breaks after irradiation of human fibroblasts deficient in glutathione. Int. J. Radiat. Biol. 40, 355-363